ELDN
ELEDON PHARMACEUTICALS INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
ELEDON PHARMACEUTICALS INC (ELDN) is held as common stock by 3 tracked hedge-fund managers, with a combined reported value of ~$5.50M; the largest are Izzy Englander, Ken Griffin, Renaissance Technologies. 1 tracked manager also disclosed PUT or CALL positions, reported separately below. This quarter: 2 new, 1 added. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · LowThis quarter · Heating up
Common-stock holders31 also report options
Congress trades0
Price$2.50vs quarter-end-36.55%
Sectors0
This quarter's moves
Top holderNew2
Added1
Trimmed / sold0
Izzy EnglanderCommon-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
| Investor | Value | % of portfolio | Action |
|---|
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $1.10M— of portfolio279,4002026 Q2
Value $60.3K— of portfolio15,3002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinPUT | $1.10M | — | — |
| Ken GriffinCALL | $60.3K | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.